Daniel Schrednitzki

Dr. Daniel Schrednitzki

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2023 in Bone & Joint Research
Verified
Journal Article
Open access
PDF file
BLBenedikt Langenberger
Benedikt Langenberger
DSDaniel Schrednitzki
Daniel Schrednitzki
AHAndreas M. Halder
Andreas M. Halder
RBReinhard Busse
Reinhard Busse
CPChristoph M. Pross
Christoph M. Pross
Aims: A substantial fraction of patients undergoing knee arthroplasty (KA) or hip arthroplasty (HA) do not achieve an improvement as high as the minimal clinically important difference (MCID), i.e. do not achieve a meaningful improvement. Using three patient-reported outcome measures (PROMs), our aim was: 1) to assess machine learning (ML), the simple pre-surgery PROM score, and logistic-regression (LR)-derived performance in their prediction of whether patients undergoing HA or KA achieve an improvement as high or higher than a calculated MCID; and 2) to test whether ML is able to outperform LR or pre-surgery PROM scores in predictive performance.Methods: MCIDs were derived using the change difference method in a sample of 1,843 HA and 1,546 KA patients. An artificial neural network, a gradient boosting machine, least absolute shrinkage and selection operator (LASSO) regression, ridge regression, elastic net, random forest, LR, and pre-surgery PROM scores were applied to predict MCID for the following PROMs: EuroQol five-dimension, five-level questionnaire (EQ-5D-5L), EQ visual analogue scale (EQ-VAS), Hip disability and Osteoarthritis Outcome Score-Physical Function Short-form (HOOS-PS), and Knee injury and Osteoarthritis Outcome Score-Physical Function Short-form (KOOS-PS).Results: Predictive performance of the best models per outcome ranged from 0.71 for HOOS-PS to 0.84 for EQ-VAS (HA sample). ML statistically significantly outperformed LR and pre-surgery PROM scores in two out of six cases.Conclusion: MCIDs can be predicted with reasonable performance. ML was able to outperform traditional methods, although only in a minority of cases.Cite this article: Bone Joint Res 2023;12(9):512–521.

21 October 2022 in Archives of orthopaedic and trauma surgery
Verified
Journal Article
Closed access
PDF file
DSDaniel Schrednitzki
Daniel Schrednitzki
CHChristoph Eckhard Horn
Christoph Eckhard Horn
ULUte Anne Lampe
Ute Anne Lampe
AHAndreas M. Halder
Andreas M. Halder

1 December 2020 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
DSDaniel Schrednitzki
Daniel Schrednitzki
ABAlexander Beier
Alexander Beier
AMAxel Marx
Axel Marx
AHAndreas M. Halder
Andreas M. Halder

9 October 2024 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
LSLukas Schöner
Lukas Schöner
DKDavid Kuklinski
David Kuklinski
LWLaura Wittich
Laura Wittich
VSViktoria Steinbeck
Viktoria Steinbeck
BLBenedikt Langenberger
Benedikt Langenberger
AGAlexander Geissler
Alexander Geissler
Background: While the effectiveness of patient-reported outcome measures (PROMs) as an intervention to impact patient pathways has been established for cancer care, it is unknown for other indications. We assessed the cost-effectiveness of a PROM-based monitoring and alert intervention for early detection of critical recovery paths following hip and knee replacement. Methods and findings: The cost-effectiveness analysis (CEA) is based on a multicentre randomised controlled trial encompassing 3,697 patients with hip replacement and 3,110 patients with knee replacement enrolled from 2019 to 2020 in 9 German hospitals. The analysis was conducted with a subset of 546 hip and 492 knee replacement cases with longitudinal cost data from 24 statutory health insurances. Patients were randomised 1:1 to a PROM-based remote monitoring and alert intervention or to a standard care group. All patients were assessed at 12-months post-surgery via digitally collected PROMs. Patients within the intervention group were additionally assessed at 1-, 3-, and 6-months post-surgery to be contacted in case of critical recovery paths. For the effect evaluation, a PROM-based composite measure (PRO-CM) was developed, combining changes across various PROMs in a single index ranging from 0 to 100. The PRO-CM included 6 PROMs focused on quality of life and various aspects of physical and mental health. The primary outcome was the incremental cost-effectiveness ratio (ICER). The intervention group showed incremental outcomes of 2.54 units PRO-CM (95% confidence interval (CI) [0.93, 4.14]; p = 0.002) for patients with hip and 0.87 (95% CI [−0.94, 2.67]; p = 0.347) for patients with knee replacement. Within the 12-months post-surgery period the intervention group had less costs of 376.43€ (95% CI [−639.74, −113.12]; p = 0.005) in patients with hip, and 375.50€ (95% CI [−767.40, 16.39]; p = 0.060) in patients with knee replacement, revealing a dominant ICER for both procedures. However, it remains unclear which step of the multistage intervention contributes most to the positive effect. Conclusions: The intervention significantly improved patient outcomes at lower costs in patients with hip replacements when compared with standard care. Further it showed a nonsignificant cost reduction in knee replacement patients. This reinforces the notion that PROMs can be utilised as a cost-effective instrument for remote monitoring in standard care settings. Trial registration: Registration: German Register for Clinical Studies (DRKS) under DRKS00019916.

9 May 2023 in Archives of orthopaedic and trauma surgery
Verified
Journal Article
Closed access
PDF file
JSJonas P. Sina
Jonas P. Sina
SSShiraz A. Sabah
Shiraz A. Sabah
DSDaniel Schrednitzki
Daniel Schrednitzki
APAndrew J. Price
Andrew J. Price
THThomas W. Hamilton
Thomas W. Hamilton
AAAbtin Alvand
Abtin Alvand

21 January 2026 in Journal of Experimental Orthopaedics
Verified
Journal Article
Open access
NMNils Meissner
Nils Meissner
SRSonia Ramos‐Pascual
Sonia Ramos‐Pascual
KOKatharina Ortwig
Katharina Ortwig
FRFloris van Rooij
Floris van Rooij
DSDaniel Schrednitzki
Daniel Schrednitzki
AHAndreas M. Halder
Andreas M. Halder
Purpose: Obesity is often considered a relative contraindication to total hip arthroplasty (THA) due to presumed increased perioperative and postoperative risk. Consequently, obese patients are often advised to lose weight prior to THA. However, the effect of preoperative weight loss on THA outcomes remains uncertain. This meta‐analysis compared outcomes in obese patients who lost weight preoperatively with those who did not. Methods: This review was performed according to Preferred Reporting Items for Systematic Reviews and Meta‐analysis (PRISMA) guidelines and registered in PROSPERO. Medline and Embase were searched on 1 February 2025. Two reviewers independently screened and extracted data from studies comparing outcomes in obese patients undergoing primary THA with and without preoperative weight loss. Outcomes of interest (complications, infections, readmissions, reoperations and revisions) were pooled via Freeman–Tukey double arcsine transformations using inverse‐variance weighting within a random‐effects model framework to calculate estimates of proportions and their corresponding p value. Results: Of 2896 identified references, 8 studies were included, resulting in 4848 patients with preoperative weight loss and 78,860 patients without. Interventions included bariatric surgery (1 study), non‐surgical measures (2) and unspecified methods (5). There were no significant differences in outcomes between groups, with regards to complication rates in the short‐term (weight loss: 14% vs. control: 8%, p = 0.163) or mid‐term (5% vs. 8%, p = 0.568), prosthetic joint infection rates in the short‐term (5% vs. 4%, p = 0.458) or mid‐term (6% vs. 4%, p = 0.289), reoperation rates in the short‐term (2% vs. 1%, p = 0.840) or mid‐term (7% vs. 4%, p = 0.139), revision rates in the short‐term (1% vs. 1%, p = 0.401) or mid‐term (3% in both groups, p = 0.906) and readmission rates (5% vs. 4%, p = 0.077). Conclusions: Preoperative weight loss in obese patients undergoing THA does not reduce the risk of postoperative complications, infections, readmissions, reoperations or revisions compared with obese patients who did not lose weight preoperatively. These findings question routine weight loss requirements and underscore the need for individualized risk assessment over body mass index alone. Level of Evidence: Level IV.